Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 20, 2009Blood

Venous Thromboembolism (VTE) and Survival in a Cancer Chemotherapy Outpatient Clinic: A Retrospective Chart Review Validation of a VTE Predictive Model.

View Full Paper
Ask AI
Bookmark
Share

Population

112 patients with solid tumors or malignant lymphoma who had undergone active chemotherapy in the last two…

Design

Cohort

Authors

JKJulia C. KearneySRSuzanne RossiKGKeren Glinert

Discussion

Loading...

Member takes

Overview

Supports Khorana stratification in chemotherapy patients; leaves open whether prophylaxis improves outcomes in high-risk groups.

Structured PICO

P
Population
112 patients with solid tumors or malignant lymphoma who had undergone active chemotherapy in the last two years at an outpatient oncology clinic.
I
Intervention
Khorana VTE predictive model risk stratification
O
Outcome
Venous thromboembolism (VTE)hard clinical

The Khorana clinical model accurately predicts VTE risk and overall mortality in cancer patients undergoing active chemotherapy, identifying high-risk patients who may benefit from primary prophylaxis.

Cite This Study

Kearney et al. (2009) studied this question.

synapsesocial.com/papers/6a7ffdc404b22a52ede4583ahttps://doi.org/10.1182/blood.v114.22.2503.2503
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Venous Thromboembolism Risk Model Predicts Early Progression and Overall Mortality in Cancer Patients Receiving Chemotherapy2008 · 15 citations
  2. 2Prediction of venous thromboembolism in cancer patients2010 · 782 citations
  3. 3Assessment of risk prediction scores for venous thromboembolism in ambulatory cancer patients with solid tumors receiving chemotherapy: A comparative analysis2024
  4. 4A Validated Risk Score for Venous Thromboembolism Is Predictive of Cancer Progression and Mortality2016 · 69 citations
  5. 5Preventing Venous Thromboembolism in Ambulatory Cancer Patients: The ONKOTEV Study2017 · 163 citations